What does KPV stand for?
KPV is the one-letter representation of Lys-Pro-Val, a tripeptide associated with the C-terminal region designated alpha-MSH(11-13).
KPV Reconstitution Calculator
Classification: Lys-Pro-Val tripeptide, corresponding to the C-terminal sequence commonly designated alpha-melanocyte-stimulating hormone residues 11–13.
Overview
KPV is the three-residue peptide Lys-Pro-Val. It is discussed in the literature as the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, often abbreviated alpha-MSH. The relationship is a sequence relationship: KPV is a short fragment associated with alpha-MSH, not a synonym for the complete hormone.
This distinction matters because a fragment and its parent peptide can have different structure, receptor interactions, distribution, and evidence. The calculator uses the name supplied by the visitor and cannot authenticate a sequence, a salt form, a counter-ion, or a certificate.
The page performs mass-and-volume arithmetic only. A visitor enters the label values they need to inspect, and the interface derives concentration and liquid volume represented by the entered mass. It does not select an amount or turn a laboratory finding into a clinical instruction.
Research context
PubMed records describe KPV in relation to alpha-MSH and examine inflammatory biology in experimental models. One study compared KPV with other melanocortin peptides and reported that its observed activity did not simply mirror canonical melanocortin-receptor signaling.
Those observations are mechanistic research, not evidence of a human indication. An experimental result can motivate additional study while leaving questions about pharmacokinetics, formulation, safety, and clinical relevance unresolved.
Evidence and regulatory status
The FDA advisory-committee page dated July 2026 identifies KPV free base and KPV acetate among bulk substances being considered for the 503A Bulks List. The page describes an advisory process; it is not an approval announcement.
The linked PubMed studies are research records. They do not confer authorization, establish product quality, or establish a clinical indication. Country-specific rules can differ, so a U.S. regulatory page should not be generalized worldwide.
Unit notes
Mass may be entered in mg or mcg. The only mass relationship used for normalization is 1 mg = 1,000 mcg.
The concentration calculation uses normalized mass divided by liquid volume in mL. The represented volume reverses that relationship using the visitor’s entered amount.
U-100 means 100 units per mL and U-40 means 40 units per mL. These scales describe a display convention; neither one identifies KPV or establishes a use.
Different syringe scales can show different unit counts for the same liquid volume. Mass requires both a volume and a concentration, so units alone are insufficient.
Limitations
- Arithmetic cannot determine whether an entry is KPV, alpha-MSH, a related fragment, or a mixture. It cannot assess sequence identity, purity, sterility, biological activity, or compatibility of a material.
- A mathematically valid result remains conditional on the visitor’s label and measurements. It should not be read as an endorsement of a product or a statement about personal suitability.
Frequently asked questions
Is KPV the same thing as full-length alpha-MSH?
No. KPV is a short sequence related to alpha-MSH, while alpha-MSH is a longer peptide hormone. The names should not be treated as interchangeable.
Does PepLedger choose a KPV amount?
No. PepLedger does not determine or recommend an amount. It performs arithmetic using values entered by the visitor.
Why does a liquid-volume entry affect KPV concentration?
Concentration is mass divided by liquid volume. Holding mass constant while changing volume necessarily changes that arithmetic ratio.
Does an FDA advisory listing mean KPV is approved?
No. The cited FDA page describes bulk-substance consideration by an advisory committee, which is distinct from approval.
Can syringe units identify KPV mass by themselves?
No. Syringe units indicate a volume scale. KPV mass can be related to that volume only after a concentration has been entered.
Sources and official references
- alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV: a potent anti-inflammatory peptide — PubMed, U.S. National Library of Medicine (2004)
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides — PubMed, U.S. National Library of Medicine (2003)
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee — U.S. Food and Drug Administration (2026)
Calculation methodology
PepLedger calculates concentration, liquid volume and syringe-scale position exclusively from the values you enter. It does not choose or recommend an amount.
View our calculation methodology and editorial standards
Last updated: September 13, 2026